Stock listing
0R2M Stock Price, News, Filings & Events — Regeneron Pharmaceuticals, Inc.
Selected listing: 0R2M · LSE · USD · GB
This page tracks Regeneron Pharmaceuticals, Inc.'s 0R2M:LSE listing on LSE in USD for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0R2M:LSE. 0R2M:LSE is the stock-level entry point for investors researching Regeneron Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 0R2M:LSE
- Asset type
- Stock
- Market cap
- $85.87B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LSE
- Currency
- USD
Regeneron Pharmaceuticals, Inc. 0R2M:LSE stock context
This page tracks Regeneron Pharmaceuticals, Inc.'s 0R2M:LSE listing on LSE in USD for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0R2M:LSE. 0R2M:LSE is the stock-level entry point for investors researching Regeneron Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Regeneron Pharmaceuticals, Inc.
Veeva Vault CRM Selected by Regeneron
August 25, 2026
Pasatru™ (garetosmab-grts) First and Only FDA-approved Treatment Demonstrating Reduction in New Heterotopic Ossification (HO) Lesions and...
August 19, 2026
Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation
July 31, 2026
Regeneron Reports Second Quarter 2026 Financial and Operating Results
July 30, 2026
Regeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast
June 25, 2026
Research Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for 0R2M:LSE.
Regeneron Pharmaceuticals, Inc. company profile
View the public company page for Regeneron Pharmaceuticals, Inc. on 6ix.
Regeneron Pharmaceuticals, Inc. news
Read company news and market updates connected to Regeneron Pharmaceuticals, Inc..
Regeneron Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Regeneron Pharmaceuticals, Inc..
Alternate listings
REGN:NASDAQ
US · USD
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is 0R2M:LSE.
RGO:GETTEX
DE · EUR
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is 0R2M:LSE.
881535:LSX
DE · EUR
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is 0R2M:LSE.
RGO:TRADEGATE
DE · EUR
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is 0R2M:LSE.
REGN:BMV
MX · MXN
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is 0R2M:LSE.
REGN34:BMFBOVESPA
BR · BRL
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is 0R2M:LSE.
REGN:BOATS
US · USD
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is 0R2M:LSE.
RGO:FWB
DE · EUR
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is 0R2M:LSE.
881535:LS
DE · EUR
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is 0R2M:LSE.
RGO:DUS
DE · EUR
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is 0R2M:LSE.
REGN:VIE
AT · EUR
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is 0R2M:LSE.
REGN:BIVA
MX · MXN
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is 0R2M:LSE.